Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Quinapril 20mg tablets
0205051Q0AAACAC
|
Quinapril hydrochloride | Quinapril hydrochloride | Cardiovascular System | 307 |
|
Quinapril 10mg tablets
0205051Q0AAABAB
|
Quinapril hydrochloride | Quinapril hydrochloride | Cardiovascular System | 147 |
|
Quinapril 40mg tablets
0205051Q0AAADAD
|
Quinapril hydrochloride | Quinapril hydrochloride | Cardiovascular System | 119 |
|
Accupro 20mg tablets
0205051Q0BBACAC
|
Accupro | Quinapril hydrochloride | Cardiovascular System | 57 |
|
Quinapril 5mg tablets
0205051Q0AAAAAA
|
Quinapril hydrochloride | Quinapril hydrochloride | Cardiovascular System | 46 |
|
Accupro 40mg tablets
0205051Q0BBADAD
|
Accupro | Quinapril hydrochloride | Cardiovascular System | 33 |
|
Accupro 10mg tablets
0205051Q0BBABAB
|
Accupro | Quinapril hydrochloride | Cardiovascular System | 30 |
|
Accupro 5mg tablets
0205051Q0BBAAAA
|
Accupro | Quinapril hydrochloride | Cardiovascular System | 8 |
|
Quinil 10mg tablets
0205051Q0BCABAB
|
Quinil | Quinapril hydrochloride | Cardiovascular System | No data available |
|
Quinil 20mg tablets
0205051Q0BCACAC
|
Quinil | Quinapril hydrochloride | Cardiovascular System | No data available |
|
Quinil 40mg tablets
0205051Q0BCADAD
|
Quinil | Quinapril hydrochloride | Cardiovascular System | No data available |
|
Quinil 5mg tablets
0205051Q0BCAAAA
|
Quinil | Quinapril hydrochloride | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.